Relationship Between Knee Osteoarthritis Severity and Fetuin-A and COMP Levels
This study aims to observe the relationship between the severity of knee osteoarthritis and the levels of Fetuin-A and COMP in your blood.
Data Collection
Collected at a single point in time - Cross-sectionalArthritis+3
+ Joint Diseases
+ Musculoskeletal Diseases
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: April 1, 2026
Actual date on which the first participant was enrolled.This study focuses on knee osteoarthritis, a condition where the cartilage in the knee joint breaks down, leading to pain and inflammation. The research aims to understand the connection between the severity of knee osteoarthritis and the levels of two specific substances in the blood, known as Fetuin-A and Cartilage Oligomeric Matrix Protein (COMP). By studying these substances, healthcare providers may gain a better understanding of the disease, potentially enabling earlier diagnosis and improved tracking of disease progression. The study involves 120 individuals with knee osteoarthritis and 60 healthy volunteers without any history of joint disorders. Participants in this observational study will undergo radiographic evaluations to assess the severity of their knee osteoarthritis. They will also be asked to complete pain severity scales, mobility metrics, and functional questionnaires to evaluate the impact of the condition on their daily lives. Blood samples will be collected from all participants to measure the levels of Fetuin-A and COMP. The study will then analyze whether the levels of these substances in the blood are significantly linked with the severity of knee joint degeneration and functional impairment.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.180 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
S.B.U. Antalya Training and Research Hospital, Department of Physical Medicine and Rehabilitation
Antalya, Turkey (Türkiye)Open S.B.U. Antalya Training and Research Hospital, Department of Physical Medicine and Rehabilitation in Google Maps